All In Biotech

Drug Trial Radar · NCT07795814

A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)

A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of EDG-15400 in Adults With Symptomatic Heart Failure With Preserved Ejection Fraction

Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

90

Planned (sponsor's estimate)

Start

Aug 25, 2026

Primary completion

Dec 2027

Study completion Dec 2027

Sponsor

Lead sponsor
Edgewise Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Aug 31, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 30 years, up to 84 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2 placebo-controlled study to evaluate the safety and tolerability of different doses of EDG-15400 in adults with heart failure with preserved ejection fraction (HFpEF).

Conditions

  • Heart Failure With Preserved Ejection Fraction

Interventions

  • EDG-15400 25 mgDrug

    EDG-15400 administered orally, once daily

  • Placebo to match EDG-15400 25 mg or 50 mgDrug

    Placebo administered orally, once daily

  • EDG-15400 50 mgDrug

    EDG-15400 administered orally, once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)Time frame: From baseline through study completion (up to 20 weeks).

Locations

28 sites in 1 country. Site status is shown where the registry gives one.

  • Local Institution - 1

    Birmingham, Alabama · Recruiting

  • Local Institution - 25

    Little Rock, Arkansas · Not yet recruiting

  • Local Institution - 2

    Beverly Hills, California · Not yet recruiting

  • Local Institution - 3

    San Diego, California · Not yet recruiting

  • Local Institution - 4

    Vista, California · Recruiting

  • Local Institution - 24

    Gainesville, Florida · Not yet recruiting

  • Local Institution - 5

    Peoria, Illinois · Recruiting

  • Local Institution - 26

    Fort Wayne, Indiana · Not yet recruiting

  • Local Institution - 6

    Indianapolis, Indiana · Not yet recruiting

  • Local Institution - 7

    Houma, Louisiana · Recruiting

  • Local Institution - 8

    Baltimore, Maryland · Not yet recruiting

  • Local Institution - 9

    Ypsilanti, Michigan · Not yet recruiting

  • Local Institution - 28

    Minneapolis, Minnesota · Not yet recruiting

  • Local Institution - 10

    Jackson, Mississippi · Not yet recruiting

  • Local Institution - 11

    Kansas City, Missouri · Not yet recruiting

  • Local Institution - 12

    St Louis, Missouri · Not yet recruiting

  • Local Institution - 13

    New York, New York · Not yet recruiting

  • Local Institution - 14

    Greensboro, North Carolina · Not yet recruiting

  • Local Institution - 15

    Cincinnati, Ohio · Not yet recruiting

  • Local Institution - 27

    Tulsa, Oklahoma · Not yet recruiting

  • Local Institution - 16

    Mechanicsburg, Pennsylvania · Not yet recruiting

  • Local Institution - 17

    Charleston, South Carolina · Not yet recruiting

  • Local Institution - 18

    Dallas, Texas · Not yet recruiting

  • Local Institution - 19

    Houston, Texas · Not yet recruiting

  • Local Institution - 20

    Houston, Texas · Not yet recruiting

  • Local Institution - 21

    Houston, Texas · Not yet recruiting

  • Local Institution - 22

    Charlottesville, Virginia · Not yet recruiting

  • Local Institution - 23

    Seattle, Washington · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.